다한증 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 약물별, 질환별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Hyperhidrosis Treatment Market size was valued at USD 707.44 Million in 2024 and is poised to grow from USD 745.64 Million in 2025 to USD 1135.68 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The global hyperhidrosis treatment market is evolving rapidly, prompted by a rise in the prevalence of the condition and an increasing demand for innovative solutions. Antiperspirants and topical treatments continue to be primary options, but the lack of permanent solutions has fueled research and development investments from market players. The disorder, affecting an estimated 3% of the U.S. population, significantly impacts social and emotional well-being, driving the need for effective therapies. Meanwhile, emerging therapeutic pipelines and favorable reimbursement policies are creating a conducive environment for market growth. Increased awareness and the prevalence of associated mental health issues, such as anxiety and depression, further emphasize the importance of addressing hyperhidrosis, ultimately expanding treatment options and market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyperhidrosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hyperhidrosis Treatment Market Segments Analysis

Global Hyperhidrosis Treatment Market is segmented by Treatment Type, Drug Type, Disease Type, End User and region. Based on Treatment Type, the market is segmented into Topical Treatments, Oral Medications, Botulinum Toxin Injections, Iontophoresis Devices, Microwave Therapy, Surgical Treatments and Others. Based on Drug Type, the market is segmented into Anticholinergics, Antiperspirants, Botulinum Toxins and Others. Based on Disease Type, the market is segmented into Primary Hyperhidrosis and Secondary Hyperhidrosis. Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Homecare Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is being driven by ongoing research among healthcare providers into the efficacy of radiofrequency microneedling treatments for hyperhidrosis patients. Stakeholders are keenly investigating whether fractional microneedle radiofrequency therapy offers lasting advantages, particularly for those suffering from primary axillary hyperhidrosis. Evaluations of these treatments utilize the hyperhidrosis disease severity scale (HDSS), which has demonstrated significant improvements in patients following the procedures. This focus on understanding long-term benefits and treatment outcomes is fostering advancements in hyperhidrosis management, ultimately enhancing the quality of life for individuals affected by this condition.

Restraints in the Global Hyperhidrosis Treatment Market

A significant limitation within the global hyperhidrosis treatment market lies in the temporary effectiveness of treatments, especially Botulinum toxin injections, which often leads to diminished patient response over time as tolerance builds. Additionally, the financial challenges associated with these treatments pose a considerable barrier, as many patients experience substantial out-of-pocket expenses due to a lack of coverage from most health insurance providers. This not only creates a financial strain but also contributes to the psychological distress faced by those seeking effective solutions for their condition, ultimately impacting their willingness to pursue treatment options.

Market Trends of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is experiencing significant growth, fueled by increasing awareness and acceptance of treatment options for excessive sweating, particularly in social and professional environments where personal appearance is paramount. Advancements in minimally invasive procedures, such as the use of onabotulinumtoxinA, are becoming preferred due to their effectiveness and rapid onset of results. A growing demographic that seeks solutions for both primary and secondary hyperhidrosis, along with an expanding portfolio of treatment options, including antiperspirants, iontophoresis, and surgical interventions, is driving market expansion. Additionally, ongoing research and clinical trials continue to enhance treatment efficacy, fostering innovation in addressing this condition.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Hyperhidrosis Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Topical Treatments
• Oral Medications
• Botulinum Toxin Injections
• Iontophoresis Devices
• Microwave Therapy
• Surgical Treatments
• Others

Global Hyperhidrosis Treatment Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Anticholinergics
• Antiperspirants
• Botulinum Toxins
• Others

Global Hyperhidrosis Treatment Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Primary Hyperhidrosis
• Secondary Hyperhidrosis

Global Hyperhidrosis Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Dermatology Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

Global Hyperhidrosis Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Drug Type, Disease Type, End User)
  • US
  • Canada
• Europe (Treatment Type, Drug Type, Disease Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Drug Type, Disease Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Drug Type, Disease Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Drug Type, Disease Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma GmbH & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brickell Biotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanix Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roivant Sciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermavant Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Candesant Biomedical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynosure, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strathspey Crown Holdings, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermadry Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hidrex GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. August Wolff GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanor Healthcare Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TheraVida, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carpe Products, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RA Fischer Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations